Please join us for a multifaceted symposium focusing on the latest developments in drug discovery for Autism Spectrum Disorder. We will have multiple speakers elucidating the topic form a variety of angles, ranging from basic research to industry perspectives. This event is supported by UCLA BRI , departments of Neurology and Neurobiology.

Speakers:

Dr. Daniel Geschwind MD PhD (UCLA Human Genetics, Neurology and Psychiatry)

Dr. James McCracken MD (UCLA Psychiatry)

Dr. Thomas Otis PhD (UCLA Neurobiology/Roche Pharmaceuticals)

Dr. Daniel Campbell PhD (USC Psychiatry)

Symposium Schedule

9:00     Opening remarks

9:15     Clinical testing of novel drugs for autism – James McCracken MD

9:45     Drug development for neurodevelopmental disorders – Thomas Otis PhD

10:15   Non-Coding RNAs in Autism: New Opportunities for Treatment Targets – Daniel Campbell PhD

10:45   Coffee break

11:00   Keynote lecture: Exploring mechanisms and therapies using In vitro and in vivo models – Daniel Geschwind MD PhD

12:00   Closing Remarks

12:15   Lunch and roundtable discussion (RSVP required)

Please follow the link below to RSVP for an informal roundtable discussion with the speakers (limited capacity). Lunch will be provided.

https://autismlunch.eventbrite.com